Literature DB >> 7561832

Regulated expression of neurofibromin in migrating neural crest cells of avian embryos.

K M Stocker1, L Baizer, T Coston, L Sherman, G Ciment.   

Abstract

Neurofibromatosis type 1 (NF1) is a common human genetic disease involving various neural crest (NC)-derived cell types, in particular, Schwann cells and melanocytes. The gene responsible for NF1 encodes the protein neurofibromin, which contains a domain with amino acid sequence homology to the ras-guanosine triphosphatase activating protein, suggesting that neurofibromin may play a role in intracellular signaling pathways regulating cellular proliferation or differentiation, or both. To determine whether neurofibromin plays a role in NC cell development, we used antibodies raised against human neurofibromin fusion proteins in western blot and immunocytochemical studies of early avian embryos. These antibodies specifically recognized the 235 kD chicken neurofibromin protein, which was expressed in migrating trunk and cranial NC cells of early embryos (E1.5 to E2), as well as in endothelial and smooth muscle cells of blood vessels and in a subpopulation of non-NC-derived cells in the dermamyotome. At slightly later stages (E3 to E5), neurofibromin immunostaining was observed in various NC derivatives, including dorsal root ganglia and peripheral nerves, as well as non-NC-derived cell types, including heart, skeletal muscle, and kidney. At still later stages (E7 to E9), neurofibromin immunoreactivity was found in almost all tissues in vivo. To determine whether the levels of neurofibromin changed during melanocyte and Schwann cell development, tissue culture experiments were performed. Cultured NC cells were found to express neurofibromin at early time points in culture, but the levels of immunoreactivity decreased as the cells underwent pigmentation. Schwann cells, on the other hand, continued to express neurofibromin in culture. These data suggest, therefore, that neurofibromin may play a role in the development of both NC cells and a variety of non-NC-derived tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561832     DOI: 10.1002/neu.480270408

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  6 in total

Review 1.  Hereditary genodermatoses with cancer predisposition.

Authors:  Meg R Gerstenblith; Alisa M Goldstein; Margaret A Tucker
Journal:  Hematol Oncol Clin North Am       Date:  2010-10       Impact factor: 3.722

2.  A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve.

Authors:  Tilat A Rizvi; Yuan Huang; Amer Sidani; Radhika Atit; David A Largaespada; Raymond E Boissy; Nancy Ratner
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

Review 3.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

4.  Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways.

Authors:  Farsad Afshinnia; Virginia Vega-Warner; Paul Killen
Journal:  Clin Kidney J       Date:  2013-04

5.  Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I.

Authors:  Antonietta Moramarco; Fabiana Mallone; Marta Sacchetti; Luca Lucchino; Emanuele Miraglia; Vincenzo Roberti; Alessandro Lambiase; Sandra Giustini
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

6.  Orthopaedic manifestations of neurofibromatosis type 1: A case report.

Authors:  Florentina Năstase; Diana Sabina Radaschin; Elena Niculeț; Andrei Vlad Brădeanu; Mădălina Codruța Verenca; Aurel Nechita; Valentin Chioncel; Lawrence Chukwudi Nwabudike; Liliana Baroiu; Eduard Drima Polea; Silvia Fotea; Lucretia Anghel; Alexandru Nechifor; Alin Laurenţiu Tatu
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.